Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Change in Accured Expenses (2016 - 2026)

Insmed's Change in Accured Expenses history spans 17 years, with the latest figure at -$497000.0 for Q1 2026.

  • Quarterly Change in Accured Expenses rose 99.19% to -$497000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $56.0 million through Mar 2026, up 620.75% year-over-year, with the annual reading at -$5.0 million for FY2025, 111.19% down from the prior year.
  • Change in Accured Expenses came in at -$497000.0 for Q1 2026, up from -$14.7 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $58.5 million in Q2 2025 to a low of -$61.5 million in Q1 2025.
  • The 5-year median for Change in Accured Expenses is $725000.0 (2024), against an average of $2.5 million.
  • The largest YoY upside for Change in Accured Expenses was 1652.97% in 2025 against a maximum downside of 900.81% in 2025.
  • Insmed's Change in Accured Expenses stood at -$27.7 million in 2022, then surged by 178.31% to $21.7 million in 2023, then surged by 89.46% to $41.1 million in 2024, then crashed by 135.79% to -$14.7 million in 2025, then soared by 96.62% to -$497000.0 in 2026.
  • Per Business Quant, the three most recent readings for INSM's Change in Accured Expenses are -$497000.0 (Q1 2026), -$14.7 million (Q4 2025), and $12.7 million (Q3 2025).